A New Precision-Medicine Therapy for Duchenne Muscular Dystrophy Recently Approved by the FDA, Nearing Approval in Canada
source: pixabay.com

A New Precision-Medicine Therapy for Duchenne Muscular Dystrophy Recently Approved by the FDA, Nearing Approval in Canada

A new treatment for Duchenne muscular dystrophy (DMD) has recently been approved by the FDA. The therapy is called viltolarsen and it was created by Nippon-Shinyaku and the National Center…

Continue Reading A New Precision-Medicine Therapy for Duchenne Muscular Dystrophy Recently Approved by the FDA, Nearing Approval in Canada
New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen
source: pixabay.com

New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen

A recent study has found a 12.5% improvement for patients with severe COVID-19 when baricitinib was used in combination with remdesivir. That means a faster recovery time for patients and…

Continue Reading New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen
Six Grants From the FDA Will Help Fund Critical Rare Disease Clinical Trials
source: pixabay.com

Six Grants From the FDA Will Help Fund Critical Rare Disease Clinical Trials

According to a story from BioSpace, the US Food and Drug Administration (FDA) recently announced that it has awarded grant funding that will go towards six clinical trials that will…

Continue Reading Six Grants From the FDA Will Help Fund Critical Rare Disease Clinical Trials
Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
source: pixabay.com

Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis

According to a story from BioSpace, a recent study conducted by the biotechnology company Goldfinch Bio in collaboration with academic partners is highlighting the importance of proteinuria in determining outcomes…

Continue Reading Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology
source: pixabay.com

Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology

As reported in Biospace, the National Organization for Rare Disorders (NORD) has just opened registration for patients to take part in a natural history study on metachromatic leukodystrophy (MLD), a…

Continue Reading Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology
Researchers Provide a Better Understanding of sJIA and Still’s Disease
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Researchers Provide a Better Understanding of sJIA and Still’s Disease

According to Healio, medical professionals from Boston Children's Hospital have conducted research that provides a better look at systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease. They looked specifically…

Continue Reading Researchers Provide a Better Understanding of sJIA and Still’s Disease
First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601
DarkoStojanovic / Pixabay

First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601

Amolyt Pharma has recently announced that they have dosed the first patient in their trial of AZP-3601, a treatment for hypoparathyroidism. According to GlobeNewswire, this treatment will adequately address the…

Continue Reading First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601
The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic
source: pixabay.com

The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic

 The United States FDA has just announced that they will be providing  6 new grants, which are worth 16 million dollars for rare disease research. These grants will last a…

Continue Reading The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic

Two Epidermolysis Bullosa Nonprofits United to Make the Largest Global Organization for EB

EB Research Partnership (EBRP) is based out of New York, United States. EB Research Foundation (EBRF) is an organization based out of Australia with the same goals. The two organizations  have…

Continue Reading Two Epidermolysis Bullosa Nonprofits United to Make the Largest Global Organization for EB
Waldenström’s Macroglobulinemia Precursor States: Could They be Key to a Cure?
source: pixabay.com

Waldenström’s Macroglobulinemia Precursor States: Could They be Key to a Cure?

On October 14th, 2020, the International Waldenström's Macroglobulinemia Foundation (IWMF) hosted a webinar featuring Dr. Irene Ghobrial of the Dana Farber Cancer Institute. The focus of her presentation was on…

Continue Reading Waldenström’s Macroglobulinemia Precursor States: Could They be Key to a Cure?
30 New Genes Affiliated with Charcot Marie Tooth Disease Identified
source: pixabay.com

30 New Genes Affiliated with Charcot Marie Tooth Disease Identified

Researchers have just uncovered 30 new genes that may cause Charcot-Marie-Tooth Disease (CMT).  These genes were uncovered using computer analyses of biological data, a process called bioinformatics. This study was published…

Continue Reading 30 New Genes Affiliated with Charcot Marie Tooth Disease Identified

Arthritis Treatment Shows Off-Target Benefits for Those Also Living with Diabetes

A recent study published in BMC Rheumatology has found that a combination therapy could have a benefit for individuals diagnosed with diabetes and ankylosing spondylitis (AS), psoriatic arthritis (PsA), or rheumatoid arthritis…

Continue Reading Arthritis Treatment Shows Off-Target Benefits for Those Also Living with Diabetes
Phase 3 Study Results Bring Hope for Children with Primary Hyperoxaluria Type 1  
source: pixabay.com

Phase 3 Study Results Bring Hope for Children with Primary Hyperoxaluria Type 1  

  According to a recent article in BioSpace, young children and infants who have been diagnosed with primary hyperoxaluria type 1 (PH1) are often faced with the use of gastrostomy…

Continue Reading Phase 3 Study Results Bring Hope for Children with Primary Hyperoxaluria Type 1